CIK 0001574235 · Non-accelerated filer<br>Smaller reporting company
Pulmatrix, Inc.
Sign in to watch- Ticker
- PULM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461821392
- Phone
- (888) 355-4440
- Business address
- 945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA, 01701
- Former names
- Ruthigen, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-28 | Munshi Amit Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-01-28 | Siegert Michelle Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +91,900 | 91,900 | ||
| 2021-01-28 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-01-28 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +565,500 | 565,500 | ||
| 2021-01-28 | Bazemore Todd Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-01-28 | Batycky Richard P. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-10-01 | Bazemore Todd Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −1,771 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +1,771 | 1,771 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −111 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +111 | 111 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −880 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +880 | 880 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −440 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +440 | 440 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −12,400 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +12,400 | 12,400 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2020-08-28 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-08-28 | GILLIS STEVEN Director | Returned to the company · Stock Option (Right to Buy) | −15,000 | 0 |
Page 2 of 8 · 154 trades